FR3008900B1 - Nanoparticules lipidiques multicompartimentees - Google Patents

Nanoparticules lipidiques multicompartimentees

Info

Publication number
FR3008900B1
FR3008900B1 FR1357363A FR1357363A FR3008900B1 FR 3008900 B1 FR3008900 B1 FR 3008900B1 FR 1357363 A FR1357363 A FR 1357363A FR 1357363 A FR1357363 A FR 1357363A FR 3008900 B1 FR3008900 B1 FR 3008900B1
Authority
FR
France
Prior art keywords
multicompartimized
lipid nanoparticles
nanoparticles
lipid
multicompartimized lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1357363A
Other languages
English (en)
French (fr)
Other versions
FR3008900A1 (fr
Inventor
Vincent Faivre
Sylviane Lesieur
Michel Ollivon
Modibo Ouattara
Cong Tri Truong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Paris Sud
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Paris Sud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1357363A priority Critical patent/FR3008900B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Paris Sud filed Critical Centre National de la Recherche Scientifique CNRS
Priority to PCT/FR2014/051922 priority patent/WO2015011419A1/fr
Priority to CA2914551A priority patent/CA2914551C/fr
Priority to CN201480041825.6A priority patent/CN105408015B/zh
Priority to US14/907,249 priority patent/US9757337B2/en
Priority to EP14750579.6A priority patent/EP3024566B1/fr
Priority to JP2016528592A priority patent/JP6489556B2/ja
Publication of FR3008900A1 publication Critical patent/FR3008900A1/fr
Application granted granted Critical
Publication of FR3008900B1 publication Critical patent/FR3008900B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
FR1357363A 2013-07-25 2013-07-25 Nanoparticules lipidiques multicompartimentees Expired - Fee Related FR3008900B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1357363A FR3008900B1 (fr) 2013-07-25 2013-07-25 Nanoparticules lipidiques multicompartimentees
CA2914551A CA2914551C (fr) 2013-07-25 2014-07-24 Nanoparticules lipidiques multicompartimentees
CN201480041825.6A CN105408015B (zh) 2013-07-25 2014-07-24 多隔室脂质纳米颗粒
US14/907,249 US9757337B2 (en) 2013-07-25 2014-07-24 Multicompartmental lipid nanoparticles
PCT/FR2014/051922 WO2015011419A1 (fr) 2013-07-25 2014-07-24 Nanoparticules lipidiques multicompartimentées
EP14750579.6A EP3024566B1 (fr) 2013-07-25 2014-07-24 Nanoparticules lipidiques multicompartimentées
JP2016528592A JP6489556B2 (ja) 2013-07-25 2014-07-24 マルチコンパートメント脂質ナノ粒子

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1357363A FR3008900B1 (fr) 2013-07-25 2013-07-25 Nanoparticules lipidiques multicompartimentees

Publications (2)

Publication Number Publication Date
FR3008900A1 FR3008900A1 (fr) 2015-01-30
FR3008900B1 true FR3008900B1 (fr) 2018-03-30

Family

ID=49378477

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1357363A Expired - Fee Related FR3008900B1 (fr) 2013-07-25 2013-07-25 Nanoparticules lipidiques multicompartimentees

Country Status (7)

Country Link
US (1) US9757337B2 (enExample)
EP (1) EP3024566B1 (enExample)
JP (1) JP6489556B2 (enExample)
CN (1) CN105408015B (enExample)
CA (1) CA2914551C (enExample)
FR (1) FR3008900B1 (enExample)
WO (1) WO2015011419A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017183635A (ja) * 2016-03-31 2017-10-05 ソニー株式会社 半導体装置、半導体装置の製造方法、集積基板、及び、電子機器
WO2020223813A1 (en) * 2019-05-07 2020-11-12 University Health Network Nanoemulsion with porphyrin shell

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
WO1995013796A1 (en) * 1993-11-16 1995-05-26 Depotech Corporation Vesicles with controlled release of actives
US5993850A (en) * 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
ATE514676T1 (de) * 1999-11-24 2011-07-15 Sugen Inc Ionisierbare indolinon derivate und deren verwendung als ptk liganden
FR2805761B1 (fr) 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
ES2617063T3 (es) * 2007-03-30 2017-06-15 Xisle Pharma Ventures Trust Composición de vesículas lipídicas bifásicas y método para tratar la displasia de cuello uterino por suministro intravaginal
EP2172263A4 (en) * 2007-07-02 2015-08-05 Nisshin Oillio Group Ltd E / H / E EMULSION COMPOSITION
EP2039352A1 (en) * 2007-09-18 2009-03-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules
CN100558459C (zh) * 2007-12-14 2009-11-11 天津理工大学 以脂质体作为微聚合器制备聚合物微球
CN101366697A (zh) * 2008-08-14 2009-02-18 沈阳万爱普利德医药科技有限公司 一种新的包含紫杉醇类物质的注射用纳米脂质载体及其制备方法

Also Published As

Publication number Publication date
JP6489556B2 (ja) 2019-03-27
US20160158153A1 (en) 2016-06-09
JP2016525143A (ja) 2016-08-22
WO2015011419A1 (fr) 2015-01-29
CN105408015A (zh) 2016-03-16
FR3008900A1 (fr) 2015-01-30
EP3024566A1 (fr) 2016-06-01
US9757337B2 (en) 2017-09-12
CA2914551A1 (fr) 2015-01-29
EP3024566B1 (fr) 2019-05-01
CN105408015B (zh) 2019-03-12
CA2914551C (fr) 2021-05-04

Similar Documents

Publication Publication Date Title
EP2833926A4 (en) NEUROPHILIC NANOPARTICLES
EP2848334A4 (en) HOLLOW METAL NANOPARTICLES
DE112014002226A5 (de) Verbundlenkerachse
EP2961395A4 (en) TARGETED NANOPARTICLES
EP2960538A4 (en) Magnetic brake
DE112014000475A5 (de) Legierungen
PT3055308T (pt) Resumo
EP3071183C0 (en) CAVITATION-INDUCING POLYMERIC NANOPARTICLES
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK2956698T3 (da) Bindestrimler
EP2956122A4 (en) SUPRAMOLECULAR MAGNETIC NANOPARTICLES
PL2945641T3 (pl) Cykloalkinowe pochodne sacharydów
DK2946640T3 (da) Langmuir-probe
DE102013106534B8 (de) Chromatographiepipettenspitze
HUE050917T2 (hu) Hidrokortizon-tartalmú készítmény
DE112014001252A5 (de) Aufbissschiene
FR3008900B1 (fr) Nanoparticules lipidiques multicompartimentees
DK2981168T3 (da) Laminitiskile
DK3003979T3 (da) Ikke-oxiderende partikler
UY4316S (es) Diseño celosías
BR112016000501A2 (pt) Nalador
FI10281U1 (fi) Rakenne
UA27947S (uk) Підшипник
UA27946S (uk) Підшипник
UA27945S (uk) Підшипник

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20210305